Cargando…

Role of novel biomarkers in kidney transplantation

Clinical application of biomarkers is an integral component of transplant care. Clinicians and scientists alike are in search of better biomarkers than the current serologic (serum creatinine, donor-specific antibodies), urine-derived (urinalysis, urine protein), and histologic ones we now use. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swanson, Kurtis J, Aziz, Fahad, Garg, Neetika, Mohamed, Maha, Mandelbrot, Didier, Djamali, Arjang, Parajuli, Sandesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504189/ https://www.ncbi.nlm.nih.gov/pubmed/32995319 http://dx.doi.org/10.5500/wjt.v10.i9.230

Ejemplares similares

The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success
por: Aziz, Fahad, et al.
Publicado: (2020)

How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy
por: Aziz, Fahad, et al.
Publicado: (2022)

Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
por: Joachim, Emily, et al.
Publicado: (2020)

Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019
por: Aziz, Fahad, et al.
Publicado: (2020)

Significance of Asymptomatic Pyelonephritis Found on Kidney Transplant Biopsy
por: Aziz, Fahad, et al.
Publicado: (2021)

Unusually high rates of acute rejection during the COVID-19 pandemic: cause for concern?
por: Aziz, Fahad, et al.
Publicado: (2020)

Pancreas Retransplant After Pancreas Graft Failure in Simultaneous Pancreas-kidney Transplants Is Associated With Better Kidney Graft Survival
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017)

Continuation of Peritoneal Dialysis in Adult Kidney Transplant Recipients With Delayed Graft Function
por: Gardezi, Ali I., et al.
Publicado: (2021)

Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies
por: Aziz, Fahad, et al.
Publicado: (2022)

Incidence and Outcomes of Significant Weight Changes After Pancreas Transplant Alone
por: Swanson, Kurtis J., et al.
Publicado: (2020)

Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients
por: Hennes, Anthony J., et al.
Publicado: (2020)

Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes
por: Garg, Neetika, et al.
Publicado: (2018)

Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression
por: Parajuli, Sandesh, et al.
Publicado: (2019)

The Trend of Serum Creatinine Does Not Predict Follow-Up Biopsy Findings Among Kidney Transplant Recipients With Antibody-Mediated Rejection
por: Parajuli, Sandesh, et al.
Publicado: (2023)

Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia
por: Alshaikh, Eman A., et al.
Publicado: (2023)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients
por: Ramakrishnan, Pavithra, et al.
Publicado: (2023)

Modest Improvements in Refractory Antibody-Mediated Rejection After Prolonged Treatment
por: Degner, Kenna R., et al.
Publicado: (2021)

Graft Function Variability and Slope and Kidney Transplantation Outcomes
por: Lyu, Beini, et al.
Publicado: (2021)

Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2021)

Post-transplant erythrocytosis after kidney transplantation: A review
por: Alzoubi, Beyann, et al.
Publicado: (2021)

Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy
por: Panzer, Sarah E., et al.
Publicado: (2019)

Induction in Pancreas Transplantation: T-cell Depletion Versus IL-2 Receptor Blockade
por: Aziz, Fahad, et al.
Publicado: (2022)

Kidney Transplant Recipients With Primary Membranous Glomerulonephritis Have a Higher Risk of Acute Rejection Compared With Other Primary Glomerulonephritides
por: Singh, Tripti, et al.
Publicado: (2017)

Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial
por: Wilson, Nancy, et al.
Publicado: (2023)

Analysis of Individual Components of Frailty in Simultaneous Pancreas and Kidney, and Solitary Pancreas Transplant Recipients
por: Parajuli, Sandesh, et al.
Publicado: (2023)

Serum Albumin Level Before Kidney Transplant Predicts Post-transplant BK and Possibly Cytomegalovirus Infection
por: Srivastava, Aniruddha, et al.
Publicado: (2020)

Geographic Distribution of Cytomegalovirus Serology in Kidney and Pancreas Transplant Recipients in the United States
por: Jorgenson, Margaret R., et al.
Publicado: (2021)

Utility of Protocol Pancreas Biopsies for De Novo Donor-specific Antibodies
por: Parajuli, Sandesh, et al.
Publicado: (2022)

Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target
por: Vidyasagar, Aparna, et al.
Publicado: (2012)

The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis
por: Danobeitia, Juan S, et al.
Publicado: (2014)

Kidney disease in non-kidney solid organ transplantation
por: Swanson, Kurtis J
Publicado: (2022)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model
por: Bath, Natalie M., et al.
Publicado: (2019)

APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model
por: Bath, Natalie M., et al.
Publicado: (2022)

Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients
por: Djamali, Arjang, et al.
Publicado: (2013)

Unveiling the Role of DNA Methylation in Kidney Transplantation: Novel Perspectives toward Biomarker Identification
por: Agodi, Antonella, et al.
Publicado: (2019)

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
por: Nickerson, Peter W., et al.
Publicado: (2022)

The Pin 1 inhibitor juglone attenuates kidney fibrogenesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model
por: Reese, Shannon, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qatbfmdlnqpf9180c3k331ds27